News

Réluma HA Filler and Réluma Kiss Launch with KFDA Approval

2025-04-08

본문

a9ec6120f2529e768a61b12c3121a389_1790735016_8769.png
Premium French hyaluronic acid meets Hexa-Matrix Crosslinking Technology
Paris, France — 8 April 2025 — Genèse Labs has launched Réluma, a facial hyaluronic acid filler line built on high-purity HA from HTL Biotechnology, France, together with the lip-dedicated Réluma Kiss, and has obtained KFDA approval for Réluma.

• Hyaluronic acid from HTL Biotechnology, France, a world-leading manufacturer of high-purity HA
• Built on proprietary Hexa-Matrix Crosslinking Technology (HMCT)
• Five-product range: Glisse, Lush, Volumie, Implant and Kiss
• KFDA approval in Korea establishes a foundation for Asian market entry
Completing the HA Portfolio, Face and Body
Having entered HA body contouring with RG60® in 2023, Genèse Labs extends its portfolio into facial HA fillers with Réluma. Practitioners can now choose HA solutions for both face and body within a single brand.
Hexa-Matrix Crosslinking Technology (HMCT)
HMCT crosslinks hyaluronic acid molecules into an organised, three-dimensional hexagonal network. Unlike conventional random crosslinking, it produces a uniform, smooth gel with greater resistance to enzymatic breakdown, improving shape retention and longevity. The Nano-Refined Grinding System (NRGS) delivers consistent extrusion force, while dialysis purification thoroughly removes BDDE — combining smooth injection with a lower risk of swelling.
Five Products, One Philosophy
• Réluma Glisse — ultra-soft gel for superficial fine lines (neck, décolleté, perioral lines, crow’s feet)
• Réluma Lush — medium-density gel for moderate wrinkles and dynamic areas such as the lips and perioral region
• Réluma Kiss — lip-dedicated filler infused with vitamin B12 for a natural rosy tone
• Réluma Volumie — high-viscosity gel for deep wrinkles and cheek, jawline and chin contouring
• Réluma Implant — ultra-high-viscosity gel for structural augmentation of the chin and jawline

The Significance of KFDA Approval
Korea is one of the most demanding and competitive filler markets in the world. Approval by the Ministry of Food and Drug Safety (KFDA) provides objective verification of quality and production standards, and supports both entry into Korea and subsequent registrations across Asia.

“Réluma was designed to deliver natural results across every area of the face through premium French raw materials and precise crosslinking technology.” — Genèse Labs, Product statement

About Genèse Labs
Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, hyaluronic acid fillers and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.


Contact
For distributor inquiries, collaborations, or product information, please contact: